跳至主要内容
临床试验/NCT04290507
NCT04290507已完成不适用

Epidemiology and Outcome of Anaphylactic Shocks Admitted to Intensive Care Unit: a French Retrospective Multicenter Study

Central Hospital, Nancy, France2 个研究点 分布在 1 个国家目标入组 339 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
339
试验地点
2
主要终点
In-ICU mortality

研究概览

简要总结

Anaphylaxis is a severe life-threatening reaction following exposure to an antigen. Its incidence is progressively increasing in the general population over years, accompanied with an increased number of hospitalizations. Although rare, this condition is often associated with a significant morbidity and mortality. The mortality rate has been recently estimated at 0.84 (95% CI, 0.79 to 0.88) per million per year in the French adult population. Age, chronic medication and cardiac or pulmonary comorbidities have been reported to increase the risk of a severe reaction. Obesity, age and cardiovascular comorbidities have been identified as risk factors for fatal anaphylaxis. However, the risk factors for death after ICU admission have not been elucidated yet.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Being > 18 years old
  • suffered an anaphylactic reaction, regardless of the location or causative allergen
  • transferred alive in an ICU

排除标准

  • dead within less than one hour after admission

结局指标

主要结局

In-ICU mortality

时间窗: Day 30

The number of participants deceased within ICU hospitalisation

次要结局

  • Amount of epinephrine(Day 30)
  • Amount of norepinephrine(Day 30)
  • Number and severity of organ failure(Day 30)
  • Volume of fluid administered(Day 30)
  • Extracorporeal life support requirement(Day 30)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验